Table 2 Types of diagnostic imaging and tests patients receive outside of their home country according to Mexican oncologists
US-based patients N = 46 | Mexico-based patients N = 26 | ||
|---|---|---|---|
Diagnostic Imaging | Computed tomography | 38 (82.6%) | 10 (38.5%) |
Magnetic resonance imaging | 33 (71.1%) | 10 (38.5%) | |
Nuclear | 32 (69.6%) | 21 (80.0%) | |
US-based patients N = 37 | Mexico-based patients N = 23 | ||
Diagnostic Testing | Biopsy | 34 (91.9%) | 8 (36.4%) |
Basic bloodwork | 21 (56.8%) | 4 (18.2%) | |
Blood-based tumor markers | 21 (56.8%) | 5 (22.7%) | |
Next-generation sequencing | 5 (13.9%) | 20 (90.9%) | |